Pay in 4 interest-free payments of $6.11 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Atorvastatin combined to interferon to verify the efficacy (ACTIVE) in relapsing-remitting active multiple sclerosis patients: a longitudinal controlled trial of combination therapy
10.1056/NEJMoa2301972 40 JantrapiromS.NimlamoolW.ChattipakornN.ChattipakornS.TemviriyanukulP.InthachatW.et al (2020)
Were there side effects
The linear elution pattern on the RP column, correlating with the carbon chain length, allows for precise prediction of the elution time for each acylcarnitine class
KhnSDzelSColzatoLNormanKGallinatJBrandmaierAMet al
In the ATTAIN-MAINTAIN trial, 205 patients taking tirzepatide and 171 patients taking semaglutide were randomized to take orforglipron or placebo (no active drug) daily for a year
US$ 28.38
US$ 27.53
US$ 25.89
US$ 29.60
